KHI Monthly Mixer: Addressing Acute Kidney Injury (AKI): Open Discussion on Future Actions and Insights

In 2022, the Kidney Health Initiative (KHI) introduced a roadmap aimed at accelerating the development of biomarkers for Acute Kidney Injury (AKI). However, innovation in this field has been limited since then. Join this mixer to delve deeper into AKI, share insights, and contribute to a dynamic discussion on the future steps needed to advance AKI innovation.

Learning Objectives:

• Understand Current Challenges and Innovations in developing drugs to prevent and treat AKI
• Discuss the landscape of AKI Biomarker and Endpoint Development, clinical trial designs
• Identify and Propose Future Directions for AKI Innovation (biomarker and therapeutic)

Register Now!